307 related articles for article (PubMed ID: 19597068)
1. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.
Sink KM; Leng X; Williamson J; Kritchevsky SB; Yaffe K; Kuller L; Yasar S; Atkinson H; Robbins M; Psaty B; Goff DC
Arch Intern Med; 2009 Jul; 169(13):1195-202. PubMed ID: 19597068
[TBL] [Abstract][Full Text] [Related]
2. Centrally Active ACEIs and cognitive decline.
Asamura T; Ohrui T; Une K; Furukawa K; Arai H
Arch Intern Med; 2010 Jan; 170(1):107-8; author reply 108. PubMed ID: 20065207
[No Abstract] [Full Text] [Related]
3. Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension.
Todd S; McGuinness B; Passmore AP
Arch Intern Med; 2010 Jan; 170(1):107. PubMed ID: 20065208
[No Abstract] [Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.
Solfrizzi V; Scafato E; Frisardi V; Seripa D; Logroscino G; Kehoe PG; Imbimbo BP; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Pilotto A; Panza F;
Age (Dordr); 2013 Apr; 35(2):441-53. PubMed ID: 22203459
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
6. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
[TBL] [Abstract][Full Text] [Related]
7. Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors.
Hebert PL; McBean AM; O'Connor H; Frank B; Good C; Maciejewski ML
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):641-8. PubMed ID: 23620414
[TBL] [Abstract][Full Text] [Related]
8. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
9. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.
Peters R; Beckett N; Nunes M; Fletcher A; Forette F; Bulpitt C
Drugs Aging; 2006; 23(1):83-92. PubMed ID: 16492072
[TBL] [Abstract][Full Text] [Related]
10. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
Böhm M; Schumacher H; Leong D; Mancia G; Unger T; Schmieder R; Custodis F; Diener HC; Laufs U; Lonn E; Sliwa K; Teo K; Fagard R; Redon J; Sleight P; Anderson C; O'Donnell M; Yusuf S
Hypertension; 2015 Mar; 65(3):651-61. PubMed ID: 25583157
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study.
Peters R; Collerton J; Granic A; Davies K; Kirkwood T; Jagger C
J Hypertens; 2015 Oct; 33(10):2156-64. PubMed ID: 26237554
[TBL] [Abstract][Full Text] [Related]
13. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
[TBL] [Abstract][Full Text] [Related]
16. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Marley JE; Morgan TO; West MJ;
N Engl J Med; 2003 Feb; 348(7):583-92. PubMed ID: 12584366
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.
de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH
Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.
Heckbert SR; Wiggins KL; Glazer NL; Dublin S; Psaty BM; Smith NL; Longstreth WT; Lumley T
Am J Hypertens; 2009 May; 22(5):538-44. PubMed ID: 19265792
[TBL] [Abstract][Full Text] [Related]
19. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
